 VOLUME
57 1996 NUMBER 8
ORIGINAL ARTICLES
329 Impact of a Smoking Ban on a Locked Psychiatric
Unit. Ellen Haller, Dale E. McNiel, and Renee L. Binder
333 Sertraline Response in Adults With Mental
Retardation and Autistic Disorder. Jessica A. Hellings, Lee Ann Kelley, William F.
Gabrielli, Earl Kilgore, and Priti Shah
337 A Pharmacoeconomic Model of Outpatient
Antipsychotic Therapy in "Revolving Door"
Schizophrenic Patients. William M. Glazer and Larry Ereshefsky
346 Effect of Fluvoxamine on Total Serum Cholesterol
Levels During Weight Reduction. Martina de Zwaan, and Detlev O. Nutzinger
349 Diazepam Versus Alprazolam for the Treatment of
Panic Disorder. Russell Noyes, Jr., Graham D. Burrows, James H. Reich,
Fiona K. Judd, Michael J. Garvey, Trevor R. Norman, Brian
L. Cook, and Peter Marriott
356 Lithium-Associated Cognitive and Functional
Deficits Reduced by a Switch to Divalproex Sodium: A Case
Series. Andrew L. Stoll, Carol A. Locke, Alexander Vuckovic, and
Pierre V. Mayer
360 Pathological Gambling in Hospitalized Substance
Abusing Veterans. Amin N. Daghestani, Eileen Elenz, and John W. Crayton
364 Structured Psychiatric Interview and Ambulatory
Sleep Monitoring in Young Psychophysiological Insomniacs. Marco Zucconi, Luigi Ferini-Strambi, Orsola Gambini,
Cinzia Castronovo, Laura Galli, Arturo Campana, Silvio
Scarone, and Salvatore Smirne
LETTERS TO THE EDITOR
371 The Suppression of Nightmares With Guanfacine. Joseph P. Horrigan and L. Jarrett Barnhill
371 Near Syncope Associated With Concomitant Clozapine
and Cocaine Use. Faiq A. Hameedi, Michael J. Sernyak, Syed A. Naqvi, and
Thomas R. Kosten
372 Zolpidem for the Treatment of Agitation in Elderly
Demented Patients. Cherry W. Jackson, Janet K. Pitner, and Jacobo E. Mintzer
373 Critique of Fluoxetine Study in PTSD. Hillel Glover
374 Breakthrough Panic After Amantadine Treatment in a
Parkinson's Disease Patient. F. Gregory Noveske
374 Correction. Antidpressants and cognitive
impairment in the elderly. (1996;57[suppl 5]:38-44) Oxman TE
ACADEMIC HIGHLIGHTS
377 New Perspectives in the Management of Depression
ACADEMIC HIGHLIGHTS
315 Advancements in CNS Drugs
|